Asterion Therapeutics SPRL
Asterion Therapeutics reported total assets of 58,464 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Asterion Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +36 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Asterion Therapeutics's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −95,406 € | ||||
| Equity | −214,025 € | ||||
| Cash | 151 € | ||||
| EBITDA | −90,968 € | ||||
| Total assets | 58,464 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 01 Oct 2025
- Year ended 31 Dec 2023filed on 27 May 2025
- Year ended 31 Dec 2022filed on 27 May 2025
- Year ended 31 Dec 2021filed on 08 Jun 2022
Asterion Therapeutics's financial analysis
- Solvency-366.1%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Asterion Therapeutics
Asterion Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0715.602.553
- VAT number
- BE0715602553
- Peppol
- Registered · 0208:0715602553 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 07 Dec 2018
- Registered office
- 9120 Beveren-Kruibeke-Zwijndrecht
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Asterion Therapeutics (SPRL) has been based in Beveren-Kruibeke-Zwijndrecht since 2018, active in: manufacture of other pharmaceutical products. For 2025, it reports a net loss of 95,406 € and equity of −214,025 €; its revenue is not published. Its solvency stands at -366.1%, below the median of its sector (47.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Asterion Therapeutics
Companies in the same business, of comparable size and area, outside its group.
- Laboratoire DIPO Manufacture of perfume and toilet preparations Etterbeek · balance sheet 24,259 €
- Smilla Retail sale of pharmaceutical products Heers · balance sheet 70,168 €
- Apego Retail sale of pharmaceutical products Geel · balance sheet 89,749 €
- Farmecha Services Retail sale of pharmaceutical products Bornem · balance sheet 72,929 €
- ES Pharma Retail sale of pharmaceutical products Mol · balance sheet 84,690 €
- Clarethis Manufacture of basic pharmaceutical products Soignies · balance sheet 172,781 €
- Conscio Manufacture of perfume and toilet preparations Tervuren · balance sheet 45,038 €
- Manon De Marez Retail sale of pharmaceutical products Herent · balance sheet 85,130 €
Frequently asked questions about Asterion Therapeutics
What is the revenue of Asterion Therapeutics?
Asterion Therapeutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Asterion Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0715602553 for Asterion Therapeutics, if the company is VAT-registered. Its company number (CBE) is 0715.602.553.
Where is the registered office of Asterion Therapeutics?
According to the CBE register, the registered office of Asterion Therapeutics is in 9120 Beveren-Kruibeke-Zwijndrecht.
What is the equity of Asterion Therapeutics?
At the close of the 2025 financial year, the equity of Asterion Therapeutics amounts to -214,025 €, a solvency of -366.1% of total assets.
Who manages Asterion Therapeutics?
The register lists 1 active mandates at Asterion Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Asterion Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →